EFFICIENCY OF USING A COMBINATION OF AVASTIN AND LOW-DOSE INTERFERON-Α2A IN THE TREATMENT OF METASTATIC RENAL CELL CARCINOMA
Due to the introduction of angiogenesis inhibitors into clinical practice to treat metastatic renal cell carcinoma, the trials dealing with the use of this class of medications are urgent. The paper gives the results of studies of the efficacy of bevacizumab in combination with low-dose interferon-α...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-08-01
|
| Series: | Onkourologiâ |
| Subjects: | |
| Online Access: | https://oncourology.abvpress.ru/oncur/article/view/237 |